TCL Archive In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State February 14, 1997
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive NCAB working Group Is Not Subject To Open Meetings Law, NCI Official Says December 9, 1994
TCL Archive Center Bitter Over NCI’s Reacting To IOM report, Core grant Losses, Program Staff Cuts June 30, 1989
TCL Archive No Justification Provided: DePinho’s Nixing of Tenure Renewals May Bring Censure to MD Anderson April 25, 2014
